북미 현장 진단 분자 진단 시장 예측(2028년) – 제품 및 서비스(분석법 및 키트, 장비, 서비스 및 소프트웨어), 기술(PCR, 등온 핵산 증폭 기술(INAAT)별 코로나19 영향 및 지역 분석) 및 기타 기술), 애플리케이션(감염병, 종양학, 혈액학, 산전 검사, 내분비학 및 기타 애플리케이션), 최종 사용자(병원 및 진료소, 진단 실험실, 연구 및 학술 기관 및 기타)

시장 소개

현장 진단 분자 진단에는 휴대용 장치, 분석 및 검사가 포함됩니다. ; 인후 면봉, 혈액, 혈청, 대변 등 인간 시료에서 질병을 탐지하고 진단하는 데 사용되는 키트입니다. 분자 진단은 중앙 집중식 실험실에서 분산형 현장 분자 검사로 전환되고 있습니다. 단순성, 편리성, 신속한 처리 시간, 환자 결과 개선 가능성으로 인해 POCT는 빠르게 주목을 받고 있습니다.

게다가 소비를 많이 하는 특정 바이러스 탐지 방법에 대한 수요가 증가하고 있습니다. 적시에 감염을 통제할 시간이 줄어들면 예측 기간 동안 시장 성장이 강화될 것으로 예상됩니다.

미국은 북미 전체 국가 중 코로나19 사례 수가 가장 많습니다. 이는 이 지역의 다양한 산업과 공급 및 유통망에 부정적인 영향을 미쳤습니다. 팬데믹 기간 동안 생명과학 기업들은 생명을 위협하는 질병 치료를 위한 신약 개발에 초점을 옮겼습니다. 또한 신속한 검사 장비에 대한 수요도 증가해 북미 현장 분자진단 시장 성장에 큰 역할을 하고 있다. 더욱이 코로나19의 지속적인 확산으로 현장진단용 분자진단키트 수요가 늘어나고 있다. 이러한 키트의 채택으로 신제품 개발 및 출시가 촉진되고 있습니다. 2021년 3월, Eurofins\' Clinical Enterprise, Inc.는 EmpowerDX 코로나19 홈 컬렉션 키트의 소비자 직접 판매(DTC) 버전에 대해 미국 식품의약국(FDA)으로부터 긴급 사용 승인(EUA)을 획득했습니다. 마찬가지로 2020년 7월 Eurofins USA의 Clinical Diagnostics는 SARS-CoV-2를 검출하기 위한 통합 PCR 테스트를 사용할 수 있다고 발표했습니다. 이를 통해 고객의 PCR 테스트당 비용이 크게 절감될 것입니다.

시장 개요 및 역학

북미 현장 진단 분자진단 시장은 다음과 같이 예상됩니다. 2021년 8억 6,090만 달러에서 2028년까지 21억 1,010만 달러 규모로 성장할 것으로 예상됩니다. 시장은 2021~2028년부터 연평균 성장률(CAGR) 13.7%로 성장할 것으로 예상됩니다. 진행 중인 코로나19(COVID-19) 대유행은 또한 POC 분자 진단 키트 제조업체에게 새로운 코로나바이러스를 탐지할 수 있는 기회를 제공했습니다. 예를 들어, 글로벌 헬스케어 및 의료 장비 제조업체인 ABBOTT는 ID NOW를 출시했습니다. 5분 이내에 새로운 코로나바이러스 감염을 감지할 수 있는 분자 현장진단 장비입니다. ID NOW는 감염성 질병을 정성적으로 탐지하기 위한 신속한 장비 기반 등온 기술입니다. 독자적인 등온 핵산 증폭 제품 & 서비스는 몇 초 만에 분자 데이터를 생성하므로 의사는 환자 방문 중에 증거 기반 치료 결정을 내릴 수 있습니다. ID NOW는 식품의약국(FDA)의 인증이나 승인을 받지 않았습니다. 이는 긴급 사용 승인(EUA)에 따라 승인된 실험실 및 환자 치료 환경에서 사용하도록 FDA의 승인을 받았습니다. 이러한 혁신과 제품 개발은 예측 기간 동안 북미 현장 진단 분자 진단 시장의 성장을 위한 수익성 있는 기회를 제공할 것으로 예상됩니다.

주요 시장 부문

제품 및amp; 서비스 중 분석 및 키트 부문은 2020년 북미 Point-of-Care 분자 진단 시장에서 가장 큰 점유율을 차지했습니다. 기술 측면에서 PCR 부문은 북미 Point-of-Care 분자 진단 시장에서 가장 큰 점유율을 차지했습니다. 2020년 진단 시장. 적용 측면에서 전염병 부문은 2020년 북미 현장 진단 분자진단 시장에서 가장 큰 점유율을 차지했습니다. 최종 사용자 측면에서는 진단 실험실 부문이 가장 큰 점유율을 차지했습니다. 2020년 북미 현장 분자 진단 시장.

주요 출처 및 회사 목록

북미 현장 진단 분자진단 시장에 대한 이 보고서를 준비하기 위해 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서 등이 있습니다. , 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation 및 Bio-Rad Laboratories, Inc.

구매 이유 보고서

북미 Point-of-Care 분자 진단 시장 환경을 이해하고 강력한 수익을 보장할 수 있는 시장 부문을 식별합니다.
끊임없이 변화하는 시장 환경을 이해하고 경쟁에서 앞서 나가기 위해
북부 지역에서 인수합병 및 파트너십 거래를 효율적으로 계획하기 위해 가장 유망한 예상 판매가 있는 세그먼트를 식별하여 미국 Point-of-Care 분자 진단 시장
다양한 세그먼트의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내립니다.
2021년~2028년 기간 동안 다양한 부문을 기반으로 북미 현장 분자 진단 시장의 시장 수익 예측을 얻으려면

북미 현장 진단 분자 진단 시장 세분화

별 제품 및amp ; 서비스

분석항목 및 키트
기기
서비스 및 소프트웨어

기술별

PCR
등온 핵산 증폭 기술(INAAT)
기타 기술

작성자 응용 프로그램

작성자 최종 사용자

병원 및 진료소
진단 실험실
연구 및 학술 기관
기타

국가별

북미
- 미국
- 캐나다
- 멕시코

언급된 회사

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2 North America Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3 North America Point-of-Care Molecular Diagnostics Market – By Application

1.3.4 North America Point-of-Care Molecular Diagnostics Market – By End User

1.3.5 North America Point-of-Care Molecular Diagnostics Market– By Geography

2. North America Point-of-Care Molecular Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 Pricing Pressures owing to Reimbursement Cuts

5.3 Market Opportunities

5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4 Future Trends

5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market– North America Analysis

6.1 North America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1 Overview

7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3 Assays and Kits

7.3.1 Overview

7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Services and Software

7.5.1 Overview

7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1 Overview

8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3 PCR

8.3.1 Overview

8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1 Overview

8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1 Overview

9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3 Infectious Disease

9.3.1 Overview

9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hematology

9.5.1 Overview

9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Prenatal Testing

9.6.1 Overview

9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Endocrinology

9.7.1 Overview

9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1 Overview

10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Laboratories

10.4.1 Overview

10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Research and Academic Institutes

10.5.1 Overview

10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11. North America Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1 North America: Point-of-Care Molecular Diagnostics Market

11.1.1 Overview

11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERIDIAN BIOSCIENCE, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Enzo Biochem Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Biocartis

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Quidel Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Danaher

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 BIO-RAD LABORATORIES INC.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 binx health, inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2. North America Point-of-Care Molecular Diagnostics Market Overview

Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in North America Point-of-Care Molecular Diagnostics Market

Figure 4. US to Show Significant Growth During Forecast Period

Figure 5. North America Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6. North America PEST Analysis

Figure 7. North America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 29. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 30. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 31. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America

Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Point-of-Care molecular diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000